Gastrointestinal Bleeding, the First Presentation of Acute GVHD in Two Patients with Thalassemia after BMT

Engraftment by donor lymphocytes in an immunologically compromised host can result in donor T-cell activation against host major histocompatibility complex antigens, with resultant GVHD."nThe acute form of GVHD (aGVHD) is characterized by erythroderma, cholestatic hepatitis, and enteritis....

Full description

Bibliographic Details
Main Authors: Ghavamzadeh A, Moosavi A, Hedayatiasl A, Taghipour R
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2004-07-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/4488.pdf&manuscript_id=4488
_version_ 1827884001440825344
author Ghavamzadeh A
Moosavi A
Hedayatiasl A
Taghipour R
author_facet Ghavamzadeh A
Moosavi A
Hedayatiasl A
Taghipour R
author_sort Ghavamzadeh A
collection DOAJ
description Engraftment by donor lymphocytes in an immunologically compromised host can result in donor T-cell activation against host major histocompatibility complex antigens, with resultant GVHD."nThe acute form of GVHD (aGVHD) is characterized by erythroderma, cholestatic hepatitis, and enteritis. The intestinal symptoms of aGVHD include crampy abdominal pain and watery diarrhea, often with blood. The conditioning regimen and infectious agents may produce similar symptoms. Severe intestinal aGVHD is a life-threatening event and associated with high mortality."nIn this case report, we describe two patients with major thalassemia who experienced acute gastrointestinal GVHD. One of them experienced it after peripheral blood transplantation at day +13, and the other after bone marrow transplantation at day +14. The first presentation was severe GI bleeding, and then 2 litters per day diarrhea. Besides standard prophylaxis with Cyclosporine and Methotrexate, Methylprednisolone 2mg/kg per day commenced because GI bleeding started and afterward supportive treatment means were continued. Following administration of Methylprednisolone, the amount of GI bleeding and diarrhea declined; in addition, the need for whole blood transfusion and blood products decreased. Both children had no problem in follow-up."nEngraftment evaluation by the VNTR method showed 100 percent validity. GI bleeding after transplantation can be a major presentation of aGVHD, which requires precise attention, and on-time treatment. The elimination of other causes of GI bleeding and diarrhea, in addition to the two other factors mentioned above, would increase the survival rate of patients greatly.
first_indexed 2024-03-12T19:21:18Z
format Article
id doaj.art-da162164dd764e54a04993dad9eaaeed
institution Directory Open Access Journal
issn 2008-3009
2008-2207
language English
last_indexed 2024-03-12T19:21:18Z
publishDate 2004-07-01
publisher Tehran University of Medical Sciences
record_format Article
series International Journal of Hematology-Oncology and Stem Cell Research
spelling doaj.art-da162164dd764e54a04993dad9eaaeed2023-08-02T05:10:58ZengTehran University of Medical SciencesInternational Journal of Hematology-Oncology and Stem Cell Research2008-30092008-22072004-07-01112831Gastrointestinal Bleeding, the First Presentation of Acute GVHD in Two Patients with Thalassemia after BMTGhavamzadeh AMoosavi AHedayatiasl ATaghipour REngraftment by donor lymphocytes in an immunologically compromised host can result in donor T-cell activation against host major histocompatibility complex antigens, with resultant GVHD."nThe acute form of GVHD (aGVHD) is characterized by erythroderma, cholestatic hepatitis, and enteritis. The intestinal symptoms of aGVHD include crampy abdominal pain and watery diarrhea, often with blood. The conditioning regimen and infectious agents may produce similar symptoms. Severe intestinal aGVHD is a life-threatening event and associated with high mortality."nIn this case report, we describe two patients with major thalassemia who experienced acute gastrointestinal GVHD. One of them experienced it after peripheral blood transplantation at day +13, and the other after bone marrow transplantation at day +14. The first presentation was severe GI bleeding, and then 2 litters per day diarrhea. Besides standard prophylaxis with Cyclosporine and Methotrexate, Methylprednisolone 2mg/kg per day commenced because GI bleeding started and afterward supportive treatment means were continued. Following administration of Methylprednisolone, the amount of GI bleeding and diarrhea declined; in addition, the need for whole blood transfusion and blood products decreased. Both children had no problem in follow-up."nEngraftment evaluation by the VNTR method showed 100 percent validity. GI bleeding after transplantation can be a major presentation of aGVHD, which requires precise attention, and on-time treatment. The elimination of other causes of GI bleeding and diarrhea, in addition to the two other factors mentioned above, would increase the survival rate of patients greatly.http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/4488.pdf&manuscript_id=4488
spellingShingle Ghavamzadeh A
Moosavi A
Hedayatiasl A
Taghipour R
Gastrointestinal Bleeding, the First Presentation of Acute GVHD in Two Patients with Thalassemia after BMT
International Journal of Hematology-Oncology and Stem Cell Research
title Gastrointestinal Bleeding, the First Presentation of Acute GVHD in Two Patients with Thalassemia after BMT
title_full Gastrointestinal Bleeding, the First Presentation of Acute GVHD in Two Patients with Thalassemia after BMT
title_fullStr Gastrointestinal Bleeding, the First Presentation of Acute GVHD in Two Patients with Thalassemia after BMT
title_full_unstemmed Gastrointestinal Bleeding, the First Presentation of Acute GVHD in Two Patients with Thalassemia after BMT
title_short Gastrointestinal Bleeding, the First Presentation of Acute GVHD in Two Patients with Thalassemia after BMT
title_sort gastrointestinal bleeding the first presentation of acute gvhd in two patients with thalassemia after bmt
url http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/4488.pdf&manuscript_id=4488
work_keys_str_mv AT ghavamzadeha gastrointestinalbleedingthefirstpresentationofacutegvhdintwopatientswiththalassemiaafterbmt
AT moosavia gastrointestinalbleedingthefirstpresentationofacutegvhdintwopatientswiththalassemiaafterbmt
AT hedayatiasla gastrointestinalbleedingthefirstpresentationofacutegvhdintwopatientswiththalassemiaafterbmt
AT taghipourr gastrointestinalbleedingthefirstpresentationofacutegvhdintwopatientswiththalassemiaafterbmt